Isis regulatory update

ISIP (Carlsbad, Calif.) was to announce today that it has received notices of allowance for four U.S. patents. Two of the allowed patents cover purine modifications that are used in ISIP's antisense oligonucleotide drugs. The modifications allow the compounds to bind more strongly to their targets, ISIP said. ...